Form 8-K ANI PHARMACEUTICALS INC For: Aug 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
ANI Pharmaceuticals (ANIP) Posts Q2 Loss of 21c/Share
August 4, 2014 8:36 AM EDTANI Pharmaceuticals (NASDAQ: ANIP) reported Q2 EPS of ($0.21), which may not compare with the analyst estimate of $0.01. Revenue for the quarter came in at $6.6 million versus the consensus estimate of $7.95 million.
Adjusted non-GAAP EBITDA was $0.2 million for the three months ended June 30, 2014,... More
